Results 31 to 40 of about 10,033 (195)
Objective: To assess esophageal involvement (EI) in juvenile localized scleroderma (JLS) population and the possible association between this gastrointestinal manifestation and demographic data, clinical features, laboratory exams, treatments and ...
Clarissa C.M. Valões +5 more
doaj +2 more sources
The localized scleroderma (morphea) is the clinical option of the juvenile scleroderma, the third in prevalence rheumatic condition in pediatrics. The article summarizes all the data on the classification, diagnostics, and differential diagnosis of ...
Rinat K. Raupov +2 more
doaj +3 more sources
Revealing Microvascular Involvement in Pediatric Localized Scleroderma Through Nailfold Capillaroscopy [PDF]
Background/Objectives: Juvenile localized scleroderma (jLoS) is a chronic inflammatory disorder with skin and subcutaneous tissue involvement. Microvascular alterations are thought to contribute to its pathogenesis.
Sema Nur Taşkın +5 more
doaj +2 more sources
New Challenging Systemic Therapies for Juvenile Scleroderma: A Comprehensive Review [PDF]
Background: Juvenile scleroderma (JS) comprises a group of rare chronic autoimmune and fibrosing disorders in children, primarily presenting as juvenile localized scleroderma (jLS) or juvenile systemic sclerosis (jSS). While jLS predominantly affects the
Chiara Sassetti +5 more
doaj +2 more sources
Background: Juvenile Localized Scleroderma (JLS) is a rare pediatric rheumatic disease characterized by inflammation and skin sclerosis. The side effect of consensus-recommended medications and the risk of disability posed challenges to the JLS treatment.
Jiaqian Zhang +5 more
openalex +2 more sources
BACKGROUND Although clinical assessment has historically been the primary method used for pediatric localized sclerosis (LS) diagnosis and staging, highfrequency ultrasonography (HFUS) is being investigated as a more accurate evaluation method for lesion.
Şeyma Türkmen +2 more
openalex +2 more sources
Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review [PDF]
Background Current treatment for localized scleroderma (LS) has been shown to halt disease activity, but little is still known about patient experiences with these treatments, nor is there consensus about optimal measurement strategies for future ...
Alexy Hernandez +5 more
doaj +2 more sources
3233 Von Willebrand Factor is Localized in the Extravascular tissue of Patients with Juvenile Scleroderma [PDF]
OBJECTIVES/SPECIFIC AIMS: To further explore the role of vWF in the pathogenesis of scleroderma by identifying its location within the tissue of sample biopsies obtained as part of routine diagnosis with the use of immuno-histochemical staining.
Natalia Vasquez Canizares +4 more
doaj +2 more sources
Background. The aim of this project is to perform immunophenotyping of patients with JLS and healthy controls to assess dysregulated immunological pathways in JLS, and to identify biomarkers able to predict clinical features. Methods.
Società Italiana di Reumatologia
doaj +2 more sources

